Edition:
United States

Guerbet SA (GRBT.PA)

GRBT.PA on Paris Stock Exchange

65.50EUR
6:22am EST
Change (% chg)

€0.00 (+0.00%)
Prev Close
€65.50
Open
€66.00
Day's High
€66.30
Day's Low
€65.30
Volume
1,430
Avg. Vol
9,097
52-wk High
€90.64
52-wk Low
€65.30

Select another date:

Thu, Feb 15 2018

BRIEF-Guerbet: FY Revenue At Constant Exchange Rates Increases To 812.4 Million Euros

* REG-GUERBET : 2017 REVENUE AT CONSTANT EXCHANGE RATES: €812.4 MILLION; +4.7%

BRIEF-Guerbet Updates On MHLW Decision In Japan

* HAS IMMEDIATELY PROCEEDED TO REQUESTED REVISION OF PRECAUTIONS FOR MAGNESCOPE Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

BRIEF-Guerbet 9 months revenue up at ‍​601.4 million euros

* 9 MONTHS REVENUE AT CURRENT EXCHANGE RATE EUR ‍​601.4 MILLION VERSUS EUR 568.4 MILLION YEAR AGO

BRIEF-Guerbet H1 net income up at 23.1 million euros

* H1 NET INCOME EUR 23.1 MILLION VERSUS EUR 12.1 MILLION YEAR AGO

BRIEF-Guerbet announces CE mark for Vectorio

* REG-GUERBET ANNOUNCES CE MARK FOR VECTORIO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-FDA approves Guerbet’S Dotarem for patients younger than two years‍​

* FDA APPROVES GUERBET’S DOTAREM (GADOTERATE MEGLUMINE) FOR PEDIATRIC PATIENTS YOUNGER THAN TWO YEARS‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Select another date: